checkAd
    Startseite > Aktien > Innoviva > Nachrichten
    Innoviva Aktie
    14,200
     
    EUR
    +1,43 %
    +0,200 EUR
    Letzter Kurs 23.04.24 Tradegate
    14,100
     
    EUR
    286 STK
    Geldkurs 08:00:17
    14,300
     
    EUR
    279 STK
    Briefkurs 08:00:17
    ISIN: US45781M1018 · WKN: A2AC9U · SYM: HVE · USA

    Neueste Nachrichten

    Innoviva Reports Fourth Quarter and Full Year 2023 Financial Results; Highlights Recent Company Progress
    29.02.24 · Business Wire (engl.) · Innoviva
    Innoviva Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
    01.11.23 · Business Wire (engl.) · Innoviva
    Innoviva to Participate in the Cantor Global Healthcare Conference
    19.09.23 · Business Wire (engl.) · Innoviva
    XACDURO, The First and Only Antibiotic Developed to Target Acinetobacter, Now Available to Treat Hospital-Acquired Bacterial Pneumonia (HABP) and Ventilator-Associated Bacterial Pneumonia (VABP) in Adults
    18.09.23 · Business Wire (engl.) · Innoviva
    Innoviva Appoints Stephen Basso as Chief Financial Officer
    25.08.23 · Business Wire (engl.) · Innoviva
    Innoviva Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress
    02.08.23 · Business Wire (engl.) · Innoviva
    Innoviva to Participate in the Goldman Sachs Annual Global Healthcare Conference
    06.06.23 · Business Wire (engl.) · Innoviva
    Innoviva Specialty Therapeutics Announces FDA Approval for XACDURO (sulbactam for injection; durlobactam for injection), Co-packaged for Intravenous Use
    24.05.23 · Business Wire (engl.) · Innoviva
    Results from Pivotal Phase 3 ATTACK Trial of Investigational Sulbactam-Durlobactam for Treatment of Serious Infections Caused by Acinetobacter Published in The Lancet Infectious Diseases
    12.05.23 · Business Wire (engl.) · Innoviva
    Innoviva Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress
    09.05.23 · Business Wire (engl.) · Innoviva
    Innoviva Announces Retirement of Board Chairman
    28.04.23 · Business Wire (engl.) · Innoviva